Physician profile
Priya Raju
NPI 1912319054
$817.63
in general payments reported to CMS, 2019-2025
15 companies · $97.45 in 2025
The $97.45 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.68 · 2020: $36.86 · 2021: $241 · 2022: $167 · 2023: $138 · 2024: $93.22 · 2025: $97.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $252.87 | 2019-2023 | |
| Exeltis, USA INC. | $91.84 | 2021-2024 | Slynd |
| Astellas Pharma US INC | $90.27 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $78.05 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.23 | 2020-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.34 | 2022 | |
| Hologic Sales and Service, LLC | $37.79 | 2024 | Aptima |
| Millicent US INC | $31.03 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Agile Therapeutics, INC. | $26.47 | 2021-2022 | |
| Pfizer INC. | $26.29 | 2025 | |
| Renovia INC | $15.54 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.60 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $14.58 | 2023 | Vivjoa |
| Scynexis, INC. | $11.87 | 2022 | |
| Myovant Sciences INC. | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Raju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.